185 related articles for article (PubMed ID: 25142970)
1. Characteristics and associations of high-mitotic-rate melanoma.
Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
[TBL] [Abstract][Full Text] [Related]
2. Scalp melanoma: Distinctive high risk clinical and histological features.
Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly JW
Australas J Dermatol; 2017 Aug; 58(3):181-188. PubMed ID: 26768190
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
5. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.
Chamberlain AJ; Fritschi L; Giles GG; Dowling JP; Kelly JW
Arch Dermatol; 2002 May; 138(5):609-14. PubMed ID: 12020221
[TBL] [Abstract][Full Text] [Related]
6. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
[TBL] [Abstract][Full Text] [Related]
7. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.
Liu W; Dowling JP; Murray WK; McArthur GA; Thompson JF; Wolfe R; Kelly JW
Arch Dermatol; 2006 Dec; 142(12):1551-8. PubMed ID: 17178980
[TBL] [Abstract][Full Text] [Related]
8. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
[TBL] [Abstract][Full Text] [Related]
9. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
10. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
11. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
12. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
[TBL] [Abstract][Full Text] [Related]
13. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
14. Age-related characteristics of cutaneous melanoma in a Spanish Mediterranean population.
Montero I; Requena C; Traves V; García-Casado Z; Kumar R; Nagore E
Int J Dermatol; 2015 Jul; 54(7):778-84. PubMed ID: 25771683
[TBL] [Abstract][Full Text] [Related]
15. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
16. The clinical presentation of the high-mitotic-rate melanoma.
Balin SJ; Barnhill RL
JAMA Dermatol; 2014 Oct; 150(10):1047. PubMed ID: 25142555
[No Abstract] [Full Text] [Related]
17. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
18. Association of clinicopathological features of melanoma with total naevus count and a history of dysplastic naevi: a cross-sectional retrospective study within an academic centre.
Tan SY; Strazzulla LC; Li X; Park JJ; Lee SJ; Kim CC
Clin Exp Dermatol; 2018 Jul; 43(5):566-572. PubMed ID: 29450912
[TBL] [Abstract][Full Text] [Related]
19. Amelanotic melanoma of the head and neck: analysis of tumor characteristics from the National Cancer Database.
Huayllani MT; Boczar D; Saleem HY; Spaulding AC; Bagaria SP; Lu X; Kassis S; Perdikis G; Forte AJ
Int J Dermatol; 2021 Mar; 60(3):347-351. PubMed ID: 33040374
[TBL] [Abstract][Full Text] [Related]
20. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
